Maureen E. Mork

1.2k total citations
35 papers, 725 citations indexed

About

Maureen E. Mork is a scholar working on Pathology and Forensic Medicine, Oncology and Cancer Research. According to data from OpenAlex, Maureen E. Mork has authored 35 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 19 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Maureen E. Mork's work include Genetic factors in colorectal cancer (22 papers), Cancer Genomics and Diagnostics (13 papers) and BRCA gene mutations in cancer (9 papers). Maureen E. Mork is often cited by papers focused on Genetic factors in colorectal cancer (22 papers), Cancer Genomics and Diagnostics (13 papers) and BRCA gene mutations in cancer (9 papers). Maureen E. Mork collaborates with scholars based in United States, Austria and Spain. Maureen E. Mork's co-authors include Sarah A. Bannon, Eduardo Vilar, Patrick M. Lynch, Y. Nancy You, Miguel A. Rodrı́guez-Bigas, Binwu Ying, Surena F. Matin, Ester Borràs, Russell R. Broaddus and Karen H. Lu and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Clinical Cancer Research.

In The Last Decade

Maureen E. Mork

32 papers receiving 715 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maureen E. Mork United States 13 431 380 195 148 131 35 725
Sarah A. Bannon United States 14 303 0.7× 285 0.8× 155 0.8× 180 1.2× 58 0.4× 33 743
Simone Snijder Netherlands 13 396 0.9× 236 0.6× 58 0.3× 55 0.4× 91 0.7× 25 625
Bonnie Shadrach United States 12 288 0.7× 323 0.8× 74 0.4× 76 0.5× 140 1.1× 17 581
Víctor Martínez Spain 10 186 0.4× 112 0.3× 144 0.7× 139 0.9× 63 0.5× 25 528
Kristina Dalberg Sweden 14 249 0.6× 330 0.9× 429 2.2× 80 0.5× 217 1.7× 18 751
Natalie Jones United States 14 406 0.9× 394 1.0× 258 1.3× 222 1.5× 243 1.9× 19 901
Э. Э. Топузов Russia 9 123 0.3× 376 1.0× 241 1.2× 131 0.9× 79 0.6× 39 583
Yan-Xia Shi China 8 138 0.3× 355 0.9× 196 1.0× 51 0.3× 110 0.8× 19 555
R. Bracci Italy 16 140 0.3× 337 0.9× 173 0.9× 66 0.4× 184 1.4× 42 768
M.A. Raja Saudi Arabia 14 98 0.2× 252 0.7× 157 0.8× 45 0.3× 109 0.8× 21 436

Countries citing papers authored by Maureen E. Mork

Since Specialization
Citations

This map shows the geographic impact of Maureen E. Mork's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen E. Mork with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen E. Mork more than expected).

Fields of papers citing papers by Maureen E. Mork

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen E. Mork. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen E. Mork. The network helps show where Maureen E. Mork may publish in the future.

Co-authorship network of co-authors of Maureen E. Mork

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen E. Mork. A scholar is included among the top collaborators of Maureen E. Mork based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen E. Mork. Maureen E. Mork is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adibi, Mehrad, Maureen E. Mork, Charles C. Guo, et al.. (2025). Genotype-Phenotype Characterization of Lynch Syndrome–associated Upper Tract Urothelial Carcinoma. European Urology Oncology.
2.
Baydogan, Seyda, Parul Agarwal, R. D. Wright, et al.. (2024). Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors. Cancer Prevention Research. 17(7). 335–342. 3 indexed citations
3.
Reyes-Uribe, Laura, Diane Weber, Maureen E. Mork, et al.. (2023). Colorectal surveillance outcomes from an institutional longitudinal cohort of lynch syndrome carriers. Frontiers in Oncology. 13. 4 indexed citations
4.
Baydogan, Seyda, et al.. (2022). Implementation of a Video-based Remote Germline Testing for Individuals With Pancreatic Ductal Adenocarcinoma. Gastroenterology. 163(1). 316–318.e1. 1 indexed citations
5.
Jesus‐Acosta, Ana De, et al.. (2022). The Evolving Paradigm of Germline Testing in Pancreatic Ductal Adenocarcinoma and Implications for Clinical Practice. Surgical pathology clinics. 15(3). 491–502. 3 indexed citations
6.
Vilar, Eduardo, et al.. (2020). Patients with unexplained mismatch repair deficiency are interested in updated genetic testing. Hereditary Cancer in Clinical Practice. 18(1). 19–19. 4 indexed citations
7.
Heald, Brandie, Heather Hampel, James M. Church, et al.. (2020). Collaborative Group of the Americas on Inherited Gastrointestinal Cancer Position statement on multigene panel testing for patients with colorectal cancer and/or polyposis. Familial Cancer. 19(3). 223–239. 34 indexed citations
8.
Mork, Maureen E., Sarah A. Bannon, Patrick M. Lynch, et al.. (2019). Outcomes of disease-specific next-generation sequencing gene panel testing in adolescents and young adults with colorectal cancer. Cancer Genetics. 235-236. 77–83. 2 indexed citations
9.
Bannon, Sarah A., Maria F. Montiel, Jennifer B. Goldstein, et al.. (2018). High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer. Cancer Prevention Research. 11(11). 679–686. 32 indexed citations
10.
Borràs, Ester, Kyle Chang, Mala Pande, et al.. (2017). In Silico Systems Biology Analysis of Variants of Uncertain Significance in Lynch Syndrome Supports the Prioritization of Functional Molecular Validation. Cancer Prevention Research. 10(10). 580–587. 12 indexed citations
11.
Goldstein, Jennifer B., William Ka Kei Wu, Ester Borràs, et al.. (2017). Can Microsatellite Status of Colorectal Cancer Be Reliably Assessed after Neoadjuvant Therapy?. Clinical Cancer Research. 23(17). 5246–5254. 30 indexed citations
12.
DiNardo, Courtney D., Sarah A. Bannon, Mark J. Routbort, et al.. (2016). Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC). Clinical Lymphoma Myeloma & Leukemia. 16(7). 417–428.e2. 66 indexed citations
13.
Mork, Maureen E., Melissa W. Taggart, Miguel A. Rodrı́guez-Bigas, et al.. (2016). Identification of MSH2 inversion of exons 1–7 in clinical evaluation of families with suspected Lynch syndrome. Familial Cancer. 16(3). 357–361. 8 indexed citations
14.
Mork, Maureen E., Ester Borràs, Melissa W. Taggart, et al.. (2016). Identification of a novel PMS2 alteration c.505C>G (R169G) in trans with a PMS2 pathogenic mutation in a patient with constitutional mismatch repair deficiency. Familial Cancer. 15(4). 587–591. 5 indexed citations
15.
Mork, Maureen E., Scott G. Hubosky, Morgan Rouprêt, et al.. (2015). Lynch Syndrome: A Primer for Urologists and Panel Recommendations. The Journal of Urology. 194(1). 21–29. 50 indexed citations
16.
Broaddus, Russell R., Y. Nancy You, Sarah Noblin, et al.. (2014). Is it all Lynch syndrome?: An assessment of family history in individuals with mismatch repair–deficient tumors. Genetics in Medicine. 17(6). 476–484. 8 indexed citations
17.
Vilar, Eduardo, Maureen E. Mork, Ester Borràs, et al.. (2014). Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer. Cancer Genetics. 207(10-12). 495–502. 14 indexed citations
18.
Bannon, Sarah A., Maureen E. Mork, Eduardo Vilar, et al.. (2014). Patient-reported disease knowledge and educational needs in Lynch syndrome: findings of an interactive multidisciplinary patient conference. Hereditary Cancer in Clinical Practice. 12(1). 1–1. 19 indexed citations
19.
Rich, Thereasa A., Mei Liu, Carol J. Etzel, et al.. (2013). Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromes. Familial Cancer. 13(2). 291–299. 57 indexed citations
20.
Pande, Mala, Chongjuan Wei, Jinyun Chen, et al.. (2012). Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry. Familial Cancer. 11(3). 441–447. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah A. Bannon Breakdown of academic impact, for papers by Simone Snijder Breakdown of academic impact, for papers by Bonnie Shadrach Breakdown of academic impact, for papers by Víctor Martínez Breakdown of academic impact, for papers by Kristina Dalberg Breakdown of academic impact, for papers by Natalie Jones Breakdown of academic impact, for papers by Э. Э. Топузов Breakdown of academic impact, for papers by Yan-Xia Shi Breakdown of academic impact, for papers by R. Bracci Breakdown of academic impact, for papers by M.A. Raja
Rankless by CCL
2026